⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Radiofrequency Ablation in Treating Patients With Bone Metastases

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Radiofrequency Ablation in Treating Patients With Bone Metastases

Official Title: A Phase I/II Study of Percutaneous Radiofrequency Ablation of Bone Metastases Using CT Guidance

Study ID: NCT00026247

Study Description

Brief Summary: RATIONALE: Radiofrequency ablation may be effective in decreasing pain from bone metastases. PURPOSE: Phase I/II trial to study the effectiveness of radiofrequency ablation in decreasing pain in patients who have bone metastases.

Detailed Description: OBJECTIVES: * Determine the side effects of radiofrequency ablation in patients with bone metastases. * Determine the effect of this regimen on pain in these patients. * Determine the effect of this regimen on mood in these patients. * Determine the effects of narcotic usage in patients treated with this regimen. * Determine the relationship between laboratory and imaging features of this treatment and the effects of the treatment in these patients. OUTLINE: This is a multicenter study. Patients undergo percutaneous CT-guided radiofrequency ablation directly to the metastatic lesion over approximately 12 minutes. Pain and mood are assessed at baseline, daily for 14 days after treatment, and at 1 and 3 months after treatment. Patients are followed at 1 week and then at 1 and 3 months. PROJECTED ACCRUAL: Approximately 75 patients will be accrued for this study within 12.5 months.

Eligibility

Minimum Age: 21 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, Alabama, United States

UMASS Memorial Cancer Center - University Campus, Worcester, Massachusetts, United States

Mallinckrodt Institute of Radiology at Washington University Medical Center, Saint Louis, Missouri, United States

Radiology Consultants, Incorporated, Youngstown, Ohio, United States

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States

Comprehensive Cancer Center at Rhode Island Hospital, Providence, Rhode Island, United States

M.D. Anderson Cancer Center at University of Texas, Houston, Texas, United States

Contact Details

Name: Damian E. Dupuy, MD

Affiliation: Rhode Island Hospital

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: